Top 5 InsurTech Startup Investors in Isle of Man in April 2025

Last updated: Apr 2025 A list of 5 angel investors and VC (Venture Capital) funds that invest in Insurtech startups based in Isle of man. We rank investors based on the number of investments they made in Insurtech companies from Isle of man. We update this investor list every month.

Top 5 InsurTech Startup Investors in Isle of Man in April 2025

Investor	InsurTech Isle of Man investments
Chris Adelsbach	1
Tom James	1
Stuart Gardner	1
Charles Delingpole	1
Will Neale	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Chris Adelsbach - Founding Partner @ Outrun Ventures

Investment focus

FinTech, Financial Services, Software
Seed, Pre-Seed, Series A
United Kingdom, United States, Ireland

Portfolio highlights

Alfa AI — Alfa AI is a recruitment technology company specializing in AI-driven hiring solutions.
WealthOS — WealthOS is an cloud-native, enterprise, core wealth management platform. Launch and run superior digital wealth management value propositions faster and cheaper.
Camion — Empowering real estate to lead the energy transition with data and insights.

Tom James - Advisor @ OneLogin

Investment focus

SaaS, Software, Artificial Intelligence
Seed, Pre-Seed, Angel
United States, United Kingdom, Germany

Portfolio highlights

Cargofy — Cargofy it's a mobile assistant, kind of a "Siri" but for truck drivers. We help truckers access to high paying loads through our app, and receive discounts on fuel, maintenance, and truck parts.
seedata.io — Honeypots, but better! Seedata.io provides cloud-native deception technology to improve threat detection with AI-driven honeypots.
MONET — Embedded finance for agencies and B2B platforms. Frictionless access to white-labelling B2B credit, global payments and new revenue streams. Offer white-label invoice finance to your network, driving growth for you and your suppliers.

Stuart Gardner

Investment focus

Funding Platform, Financial Services, Customer Service
Pre-Seed, Seed, Angel
United Kingdom, United States, Isle of Man

Portfolio highlights

Fundably — Fundably - Get The Right UK Business Loan | Access £1k-£2m
MONET — Embedded finance for agencies and B2B platforms. Frictionless access to white-labelling B2B credit, global payments and new revenue streams. Offer white-label invoice finance to your network, driving growth for you and your suppliers.
VIAN Therapeutics — VIAN Therapeutics is an early-stage biotechnology company focused on transforming retinal disease treatment. With a first-in-class, non-invasive eyedrop as its lead product, VIAN aims to replace invasive injections for conditions like age-related macular degeneration (AMD) and diabetic macular edema (DME). Backed by strong preclinical data andongoing clinical testing, VIAN is positioned to address significant unmet medical needs and disrupt the $15 billion retinal disease market.

Charles Delingpole is Founder and CEO of ComplyAdvantage, a technology company focused on wiping out financial crime using Machine Learning. As CEO, Charles leads the product development and growth of the company. His passion for the issue came from his time as the MLRO of a previous startup he founded when he realized how inefficient processesaround money laundering are. Charles previously worked at The Student Room as a Founder and CEO. He attended the University of Cambridge and The London School of Economics and Political Science (LSE).Over 99% of money laundering is successful, ComplyAdvantage is working to stop it completely. Founded in 2014 with offices in London, New York, Singapore, and Cluj, ComplyAdvantage work with over 350 firms across 45 countries. Charles set up his first company, The Student Room Group, now the world’s largest student discussion forum when he was 16. After completing his MA in Politics at Trinity College Cambridge, and then an MSc in Management, Strategy, and Finance from the LSE, he became an associate at J.P. Morgan Cazenove.